|
Normal thyroid (n.4)
|
Hyperplasia/Benign nodules (n.5)
|
Thyroid carcinoma (n.7)
|
---|
Video intensity UCAIGg
| |
Video intensity difference
|
11.3 (9.4-14.7)
|
12.2 (8.5-19.6)
|
19.4 (11.4-22.6)
|
Video intensity UCAVEGFR2
| |
Video intensity difference
|
10.9 (10.3-14.9)
|
13.3 (10.8-15.8)
|
30.1 (25.1-35.6)* §
|
- * Statistical significant difference between Thyroid carcinoma and normal thyroid or Hyperplasia/benign nodules p<0.05.
- § Statistical significant difference between UCA targeted with anti-VEGFR2 monoclonal antibody and isotype control antibody p=0.0156.